IHAM
SAGE
Integral Health Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-200,000
| Closed | -$3.75M | – | 94 |
|
|
2024
Q1 | $3.75M | Hold |
200,000
| – | – | 0.35% | 67 |
|
|
2023
Q4 | $4.33M | Buy |
+200,000
| New | +$4.33M | 0.59% | 55 |
|
|
2023
Q3 | – | Sell |
-80,000
| Closed | -$3.76M | – | 88 |
|
|
2023
Q2 | $3.76M | Sell |
80,000
-165,000
| -67% | -$7.76M | 0.47% | 61 |
|
|
2023
Q1 | $10.3M | Sell |
245,000
-115,000
| -32% | -$4.83M | 2.07% | 16 |
|
|
2022
Q4 | $13.7M | Buy |
360,000
+3,000
| +0.8% | +$114K | 2.88% | 10 |
|
|
2022
Q3 | $14M | Sell |
357,000
-55,257
| -13% | -$2.16M | 2.72% | 10 |
|
|
2022
Q2 | $13.3M | Buy |
412,257
+101,257
| +33% | +$3.27M | 2.74% | 11 |
|
|
2022
Q1 | $10.3M | Sell |
311,000
-98,000
| -24% | -$3.24M | 2.68% | 9 |
|
|
2021
Q4 | $17.4M | Buy |
409,000
+90,000
| +28% | +$3.83M | 4.81% | 2 |
|
|
2021
Q3 | $14.1M | Buy |
319,000
+95,000
| +42% | +$4.21M | 4.06% | 3 |
|
|
2021
Q2 | $12.7M | Buy |
224,000
+80,000
| +56% | +$4.54M | 3.5% | 5 |
|
|
2021
Q1 | $10.8M | Sell |
144,000
-51,000
| -26% | -$3.82M | 3.08% | 7 |
|
|
2020
Q4 | $16.9M | Sell |
195,000
-35,000
| -15% | -$3.03M | 5.02% | 1 |
|
|
2020
Q3 | $14.1M | Buy |
230,000
+35,000
| +18% | +$2.14M | 4.3% | 2 |
|
|
2020
Q2 | $8.11M | Buy |
195,000
+25,000
| +15% | +$1.04M | 2.43% | 12 |
|
|
2020
Q1 | $4.88M | Buy |
170,000
+50,000
| +42% | +$1.44M | 2.15% | 18 |
|
|
2019
Q4 | $8.66M | Buy |
+120,000
| New | +$8.66M | 3.37% | 10 |
|